{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:40:21Z","timestamp":1789756821308,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007708","name":"Fondo Nacional de Ciencia Tecnolog\u00c3\u00ada e Innovaci\u00c3\u00b3n","doi-asserted-by":"publisher","award":["2012-00-1701"],"award-info":[{"award-number":["2012-00-1701"]}],"id":[{"id":"10.13039\/501100007708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.actatropica.2018.06.001","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T17:44:12Z","timestamp":1528220652000},"page":"261-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Successful treatment against American cutaneous leishmaniasis by intralesional infiltration of a generic antimonial compound-lidocaine combination. A follow up study"],"prefix":"10.1016","volume":"185","author":[{"given":"N\u00e9stor","family":"A\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustina","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Vicente","family":"Scorza-Dagert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.actatropica.2018.06.001_bib0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2005.73.79","article-title":"Successful treatment of refractory cutaneous leishmaniasis with GM-CSF and antimonials","volume":"73","author":"Almeida","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.actatropica.2018.06.001_bib0010","first-page":"55","article-title":"Evaluation of conventional serological tests for the diagnosis of American cutaneous leishmaniasis","volume":"47","author":"A\u00f1ez","year":"2007","journal-title":"Bol. Mal. Salud. Amb."},{"issue":"3","key":"10.1016\/j.actatropica.2018.06.001_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","article-title":"Local or systemic treatment for New world cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal","volume":"4","author":"Blum","year":"2012","journal-title":"Int. Health"},{"issue":"9","key":"10.1016\/j.actatropica.2018.06.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184777","article-title":"Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: a systematic review","volume":"12","author":"Brito","year":"2017","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.actatropica.2018.06.001_bib0025","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1590\/0074-02760160183","article-title":"Intralesional meglumine antimoniate for the treatment of localized cutaneous leishmaniasis","volume":"111","author":"Da Silva","year":"2016","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"6","key":"10.1016\/j.actatropica.2018.06.001_bib0030","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1590\/0037-8682-0213-2016","article-title":"Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis","volume":"49","author":"Duque","year":"2016","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2018.06.001_bib0035","first-page":"11","article-title":"Visceral leishmaniasis treatment: what do we have, what do we need and how to deliver it?","volume":"2","author":"Freitas-Junior","year":"2012","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"1","key":"10.1016\/j.actatropica.2018.06.001_bib0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/clinids\/18.1.83","article-title":"Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis","volume":"18","author":"Gasser","year":"1994","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.actatropica.2018.06.001_bib0045","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/JCM.36.7.1989-1995.1998","article-title":"Single- step multiplex PCR assay for characterization of new world Leishmania complexes","volume":"36","author":"Harris","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.actatropica.2018.06.001_bib0050","first-page":"69","article-title":"Review of the current treatments for leishmaniasis","volume":"3","author":"Lindoso","year":"2012","journal-title":"Res. Rep. Trop. Med."},{"key":"10.1016\/j.actatropica.2018.06.001_bib0055","doi-asserted-by":"crossref","first-page":"S257","DOI":"10.1016\/j.medmal.2007.08.001","article-title":"Cardiotoxicity of n- methyl- glucamine antimoniate (Glucantime). A case report","volume":"3","author":"Matoussi","year":"2007","journal-title":"Med. Mal. Inf."},{"key":"10.1016\/j.actatropica.2018.06.001_bib0060","series-title":"Kinetoplastid Biology and Disease 6:3","article-title":"Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis","author":"Modabber","year":"2007"},{"key":"10.1016\/j.actatropica.2018.06.001_bib0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0035-9203(90)90321-5","article-title":"Lon- term follow up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime\u00ae","volume":"84","author":"Netto","year":"1990","journal-title":"Trans. Roy. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2018.06.001_bib0070","first-page":"560","article-title":"Antimony speciation in human blood samples from patients treated with ulamina; A novel experimental drug for leishmaniasis","volume":"8","author":"Petit de Pe\u00f1a","year":"2004","journal-title":"Metal Ions Biol. Med."},{"issue":"5","key":"10.1016\/j.actatropica.2018.06.001_bib0075","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1128\/AAC.42.5.1076","article-title":"Characterization of the antimonial antileishmanial agent meglumine antimonate (Glucantime)","volume":"42","author":"Roberts","year":"1998","journal-title":"Antimicrob. Agent. Chem."},{"issue":"4","key":"10.1016\/j.actatropica.2018.06.001_bib0080","first-page":"57","article-title":"Leishmania braziliensis-GPI anchored membrane proteins as an alternative tool for specific sero-diagnosis of active American cutaneous leishmaniasis","volume":"2","author":"Rojas","year":"2015","journal-title":"Am. J. Microbiol. Biotech."},{"issue":"5","key":"10.1016\/j.actatropica.2018.06.001_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178592","article-title":"Low versus high dose of antimony for American cutaneous leishmaniasis: a randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil","volume":"12","author":"Saheki","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.actatropica.2018.06.001_bib0090","article-title":"S\u00edntesis de un complejo antimonial pentavalente (Ulamina) y su aplicaci\u00f3n experimental para el tratamiento de leishmaniasis cut\u00e1nea localizada en Venezuela","volume":"46","author":"Scorza Dagert","year":"2006","journal-title":"Bol. Mal. Salud Amb."},{"key":"10.1016\/j.actatropica.2018.06.001_bib0095","series-title":"M. Sc. Thesis (Protozoology)","article-title":"S\u00edntesis de un derivado antimonial potencialmente leishmanicida. Estudio farmacocin\u00e9tico (concentraciones tisulares) y toxicol\u00f3gico en dos modelos animales","author":"Scorza-Dagert","year":"2000"},{"key":"10.1016\/j.actatropica.2018.06.001_bib0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.curtheres.2006.06.005","article-title":"Pharmacokinetics of experimental pentavalent antimony after an intramuscular administration in adult volunteers","volume":"67","author":"V\u00e1squez","year":"2006","journal-title":"Cur. Ther. Res. Clin. Exp."},{"issue":"1","key":"10.1016\/j.actatropica.2018.06.001_bib0105","first-page":"27","article-title":"Disposici\u00f3n farmacocin\u00e9tica de las especies de antimonio en perros despu\u00e9s de una dosis de antimoniato de meglumina (Glucantime\u00ae)","volume":"48","author":"V\u00e1squez de Ricciardi","year":"2008","journal-title":"Bol. Mal. Salud Amb."},{"key":"10.1016\/j.actatropica.2018.06.001_bib0110","series-title":"M.Sc. Thesis","article-title":"Tratamiento intralesional comparativo de la leishmaniasis cut\u00e1nea localizada; utilizando dos antimoniales pentavalentes: N- Metil Glucamina (Glucantime\u00ae) y ulamina","author":"Villegas","year":"2000"},{"key":"10.1016\/j.actatropica.2018.06.001_bib0115","first-page":"xii","article-title":"Control of the Leishmaniases: report of a meeting of the WHO expert committee on the control of leishmaniases","volume":"949","author":"WHO","year":"2010"},{"issue":"2","key":"10.1016\/j.actatropica.2018.06.001_bib0120","first-page":"71","article-title":"Intralesional chemotherapy with meglumine plus lidocaine of localized cutaneous leishmaniasis in Trujillo state","volume":"35","author":"Y\u00e9pez","year":"1995","journal-title":"Venezuela. Bol. Malariol. San. Amb."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X1830038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X1830038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:14:15Z","timestamp":1757549655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X1830038X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":24,"alternative-id":["S0001706X1830038X"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2018.06.001","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment against American cutaneous leishmaniasis by intralesional infiltration of a generic antimonial compound-lidocaine combination. A follow up study","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2018.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}